Annual report pursuant to Section 13 and 15(d)

Cover

v3.24.3
Cover - USD ($)
 12 Months Ended
Jul. 31, 2024
Oct. 25, 2024
Jan. 31, 2024
Document Information [Line Items]      
Document Type 10-K    
Document Annual Report true    
Document Transition Report false    
Document Financial Statement Error Correction [Flag] false    
Entity Interactive Data Current Yes    
ICFR Auditor Attestation Flag false    
Amendment Flag false    
Document Period End Date Jul. 31, 2024    
Document Fiscal Year Focus 2024    
Document Fiscal Period Focus FY    
Documents Incorporated by Reference [Text Block]

Portions of the definitive Proxy Statement to be delivered to shareholders in connection with the Annual Meeting of Shareholders to be held on or before January 31, 2025 are incorporated by reference into Part III of this annual report.

    
Entity Information [Line Items]      
Entity Registrant Name ENZO BIOCHEM, INC.    
Entity Central Index Key 0000316253    
Entity File Number 001-09974    
Entity Tax Identification Number 13-2866202    
Entity Incorporation, State or Country Code NY    
Current Fiscal Year End Date --07-31    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Shell Company false    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Public Float     $ 57,494,000
Entity Contact Personnel [Line Items]      
Entity Address, Address Line One 21 Executive Blvd    
Entity Address, Address Line Two Farmingdale    
Entity Address, City or Town NY    
Entity Address, State or Province NY    
Entity Address, Postal Zip Code 11735    
Entity Phone Fax Numbers [Line Items]      
City Area Code (631)    
Local Phone Number 755-5500    
Entity Listings [Line Items]      
Title of 12(b) Security Common Stock, $.01 par value    
Trading Symbol ENZ    
Security Exchange Name NYSE    
Entity Common Stock, Shares Outstanding   52,244,074